Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03170219 · ClinicalTrials.gov registry record · Phase 2
Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study
A Phase 2 study, sponsored by Adrian Hernandez.
- Terminated
- Registry status
- Phase 2
- Development phase
- 11
- Enrollment target
NCT03170219: Clinical Trial Phase 2 study, sponsored by Adrian Hernandez.
NCT03170219 is a Phase 2 study that was terminated before completion, run by Adrian Hernandez. The registered enrollment target is 11 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03170219, a Phase 2 study, was terminated before completion, sponsored by Adrian Hernandez.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 11 participants
- Enrollment target
Study Summary
To determine if a strategy of early discharge using a novel subcutaneous delivery system for parenteral furosemide can improve clinical outcomes within 30 days of randomization (days alive and outside the hospital) compared to usual care.
Primary Outcome
measured by serious adverse events
Interventions
- COMBINATION_PRODUCT subcutaneous furosemide and sc2wear device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2018-04-27 |
| Est. Completion | 2018-09-20 |
| Phase | Phase 2 |
Why NCT03170219 stopped before completion
NCT03170219 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 1 intervention - of which subcutaneous furosemide and sc2wear device is the first listed.
NCT03170219 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03170219 about?
NCT03170219 is a clinical study titled "Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study". To determine if a strategy of early discharge using a novel subcutaneous delivery system for parenteral furosemide can improve clinical outcomes within 30 days of randomization (days alive and outside the hospital) compared to usual care.
What is the current status of trial NCT03170219?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 11 participants. The study started on 2018-04-27. Estimated completion is 2018-09-20.
What interventions are being tested in trial NCT03170219?
The interventions under investigation include: subcutaneous furosemide and sc2wear device (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT03170219?
This trial is sponsored by Adrian Hernandez, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03170219's enrollment target sits among peer trials
11 1967th of 2000 higher than 33 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI